Patients with cystic fibrosis demonstrate a defect in HCO3- secretion by their pancreatic duct cells. However, attempts toward understanding or correcting this defect have been hampered by a lack of knowledge regarding the cellular and molecular mechanisms mediating HCO3- transport in these cells. Recent functional and molecular studies indicate a major role for a basolateral electrogenically-driven Na+:HCO3-cotransporter (NBC1) in mediating the transport of HCO3- into the duct cells. The HCO3- exits at the lumen predominantly via two recently discovered apical HCO3-transporters. cAMP, which mediates th
The pancreatic duct expresses cystic fibrosis transmembrane conductance regulator (CFTR) and HCO3- s...
AbstractCystic fibrosis (CF) is a severely life-shortening genetic disease resulting from mutations ...
BACKGROUND & AIMS: Cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channels pla...
Increasing evidence suggests that protein-protein interaction is essential in many biological proces...
Disruption of normal cystic fibrosis transmembrane conductance regulator- (CFTR)-mediated Cl(-) tran...
Disruption of normal cystic fibrosis transmembrane conductance regulator-(CFTR)-mediated Cl- transpo...
Thanks to recent progress in availability of molecular and functional techniques it became possible ...
Cystic fibrosis (CF) takes its name from the pathological changes that occur in the pancreas. Cystic...
While cystic fibrosis transmembrane conductance regulator (CFTR) is well known to function as a Cl-c...
Cystic fibrosis (CF) is a disease caused by mutations in the cystic fibrosis transmembrane conductan...
Pancreatic duct epithelium secretes a HCO3--rich isotonic fluid that is dependent on the activity of...
Aberrant HCO3- transport is a hallmark of cystic fibrosis (CF) and is associated with aberrant Cl--d...
The secretory epithelia of the pancreatic duct and airway share the ability to generate HCO3--rich f...
Early studies showed that airway cells secreteHCO3 2 in response to cAMP-mediated agonists andHCO3 2...
For more than 20 years, the abnormally thick mucus (mucoviscidosis) in cystic fibrosis has been wide...
The pancreatic duct expresses cystic fibrosis transmembrane conductance regulator (CFTR) and HCO3- s...
AbstractCystic fibrosis (CF) is a severely life-shortening genetic disease resulting from mutations ...
BACKGROUND & AIMS: Cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channels pla...
Increasing evidence suggests that protein-protein interaction is essential in many biological proces...
Disruption of normal cystic fibrosis transmembrane conductance regulator- (CFTR)-mediated Cl(-) tran...
Disruption of normal cystic fibrosis transmembrane conductance regulator-(CFTR)-mediated Cl- transpo...
Thanks to recent progress in availability of molecular and functional techniques it became possible ...
Cystic fibrosis (CF) takes its name from the pathological changes that occur in the pancreas. Cystic...
While cystic fibrosis transmembrane conductance regulator (CFTR) is well known to function as a Cl-c...
Cystic fibrosis (CF) is a disease caused by mutations in the cystic fibrosis transmembrane conductan...
Pancreatic duct epithelium secretes a HCO3--rich isotonic fluid that is dependent on the activity of...
Aberrant HCO3- transport is a hallmark of cystic fibrosis (CF) and is associated with aberrant Cl--d...
The secretory epithelia of the pancreatic duct and airway share the ability to generate HCO3--rich f...
Early studies showed that airway cells secreteHCO3 2 in response to cAMP-mediated agonists andHCO3 2...
For more than 20 years, the abnormally thick mucus (mucoviscidosis) in cystic fibrosis has been wide...
The pancreatic duct expresses cystic fibrosis transmembrane conductance regulator (CFTR) and HCO3- s...
AbstractCystic fibrosis (CF) is a severely life-shortening genetic disease resulting from mutations ...
BACKGROUND & AIMS: Cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channels pla...